Elysium
company
About
Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $40M
- Industries
- Health Care,Life Science,Personal Health,Pharmaceutical
- Founded date
- Jan 1, 2014
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Elysium Health offers health products built with science such as dietary supplements and anti-aging drugs. It seeks to solve challenges in health with science, to help people live healthier and longer lives. It works directly with the scientists, clinicians, and health professionals around the world to identify and develop the natural compounds. Its product is a proprietary formulation of two ingredients designed to support long-term well-being at the cellular level.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$60M
Elysium has raised a total of
$60M
in funding over 2 rounds. Their latest funding was raised on
Dec 23, 2019 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 23, 2019 | Series C | $40M | 1 | — | — | Detail |
| Dec 6, 2016 | Series B | $20M | 1 |
General Catalyst
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Elysium is funded by 1 investors.
General Catalyst
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
General Catalyst
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
